XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 174 $ 334
Receivables, net 1,434 1,146
Inventories 174 125
Other current assets 66 66
Total current assets 1,848 1,671
Equity method investments 421 577
Property, plant and equipment, net of accumulated depreciation, depletion and amortization of $25,377 and $23,876 17,411 17,377
Other noncurrent assets 239 315
Total assets 19,919 19,940
Current liabilities:    
Accounts payable 1,582 1,279
Commercial paper 450 0
Payroll and benefits payable 67 90
Accrued taxes 128 171
Other current liabilities 279 364
Long-term debt due within one year 400 402
Total current liabilities 2,906 2,306
Long-term debt 4,876 5,521
Deferred tax liabilities 386 167
Defined benefit postretirement plan obligations 94 100
Asset retirement obligations 308 295
Deferred credits and other liabilities 123 154
Total liabilities 8,693 8,543
Commitments and contingencies (Note 21)
Stockholders’ Equity    
Preferred stock – no shares issued or outstanding (no par value, 26 million shares authorized) 0 0
Common stock:    
Issued – 937 million shares (par value $1 per share, 1.925 billion shares authorized at September 30, 2023 and December 31, 2022) 937 937
Held in treasury, at cost – 347 million shares and 304 million shares (8,598) (7,512)
Additional paid-in capital 7,163 7,203
Retained earnings 11,634 10,663
Accumulated other comprehensive income 90 106
Total stockholders’ equity 11,226 11,397
Total liabilities and stockholders’ equity $ 19,919 $ 19,940